| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an anticancer drug containing an anti-PD-1 antibody or an anti-PD-L1 antibody, which can be used very favorably for treating cancer, particularly metastatic cancer. Ž<P>SOLUTION: The anticancer drug is characterized by recovering reactivity of an iNKT cell to which anergy is induced by administration of an iNKT cell ligand, and comprises an iNKT cell ligand as a first anticancer drug, and an anti-PD-1 antibody or an anti-PD-L1 antibody as a second anticancer drug. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
|
